DL-去甲肾上腺素 盐酸盐结构式
|
常用名 | DL-去甲肾上腺素 盐酸盐 | 英文名 | DL-Norepinephrine hydrochloride |
---|---|---|---|---|
CAS号 | 55-27-6 | 分子量 | 205.639 | |
密度 | 1.397g/cm3 | 沸点 | 442.6ºC at 760mmHg | |
分子式 | C8H12ClNO3 | 熔点 | 140-144ºC (dec.) | |
MSDS | 美版 | 闪点 | 221.5ºC | |
符号 |
GHS06 |
信号词 | Danger |
DL-去甲肾上腺素 盐酸盐用途DL-Norepinephrine hydrochloride 是模拟内源性去甲肾上腺素的拟交感神经作用的合成苯乙胺。DL-Norepinephrine hydrochloride 是一种靶向 α1 adrenoceptor 和 β1 adrenoceptor 的神经递质,可降低心内膜下氧分压。 |
中文名 | DL-正肾上腺素盐酸盐 |
---|---|
英文名 | dl-noradrenaline hydrochloride |
中文别名 | 去甲肾上腺素盐酸盐 | DL-去甲肾上腺素盐酸盐 |
英文别名 | 更多 |
描述 | DL-Norepinephrine hydrochloride 是模拟内源性去甲肾上腺素的拟交感神经作用的合成苯乙胺。DL-Norepinephrine hydrochloride 是一种靶向 α1 adrenoceptor 和 β1 adrenoceptor 的神经递质,可降低心内膜下氧分压。 |
---|---|
相关类别 | |
靶点 |
IC50: α1 adrenoceptor and β1 adrenoceptor[1] |
参考文献 |
密度 | 1.397g/cm3 |
---|---|
沸点 | 442.6ºC at 760mmHg |
熔点 | 140-144ºC (dec.) |
分子式 | C8H12ClNO3 |
分子量 | 205.639 |
闪点 | 221.5ºC |
精确质量 | 205.050568 |
PSA | 86.71000 |
LogP | 1.59220 |
外观性状 | crystalline | off-white to tan |
储存条件 | 2-8°C |
符号 |
GHS06 |
---|---|
信号词 | Danger |
危害声明 | H301 |
警示性声明 | P301 + P310 |
个人防护装备 | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
危害码 (欧洲) | T |
风险声明 (欧洲) | R25 |
安全声明 (欧洲) | 36/37/39-45 |
危险品运输编码 | UN 2811 |
WGK德国 | 3 |
RTECS号 | DN6650000 |
包装等级 | III |
危险类别 | 6.1(b) |
海关编码 | 2922509090 |
~99% DL-去甲肾上腺素 盐酸盐 55-27-6 |
文献:Bernini, Roberta; Crisante, Fernanda; Barontini, Maurizio; Fabrizi, Giancarlo Synthesis, 2009 , # 22 art. no. P09409SS, p. 3838 - 3842 |
~95% DL-去甲肾上腺素 盐酸盐 55-27-6 |
文献:NEON LABORATORIES LTD.; DALVI, Mahesh Bhagoji; KENNY, Rajesh Shashikant; KAWLE, Ganesh Ramachandra Patent: WO2013/8247 A1, 2013 ; Location in patent: Page/Page column 10 ; |
海关编码 | 2922509090 |
---|---|
中文概述 | 2922509090. 其他氨基醇酚、氨基酸酚及其他含氧基氨基化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:AB. 最惠国关税:6.5%. 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装 |
监管条件 | A.入境货物通关单 B.出境货物通关单 |
检验检疫 | R.进口食品卫生监督检验 S.出口食品卫生监督检验 |
Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Sympathetic activity induced by naloxone-precipitated morphine withdrawal is blocked in genetically engineered mice lacking functional CRF1 receptor.
Toxicol. Appl. Pharmacol. 283(1) , 42-9, (2015) There is large body evidence indicating that stress can lead to cardiovascular disease. However, the exact brain areas and the mechanisms involved remain to be revealed. Here, we performed a series of... |
|
An assessment of norepinephrine mediated hypertrophy to apoptosis transition in cardiac cells: a signal for cell death.
Chem. Biol. Interact. 225 , 54-62, (2015) Heart is an organ which is under a constant work load that generates numerous stress responses. Heart failure is associated with increased plasma norepinephrine (NE) and hypertrophic cell death. Withi... |
|
Relationship between noradrenaline release in the locus coeruleus and antiallodynic efficacy of analgesics in rats with painful diabetic neuropathy.
Life Sci. 92(23) , 1138-44, (2013) In animal models of neuropathic pain, the noradrenergic descending pain inhibitory pathways from the locus coeruleus (LC) may be suppressed. However, no study has investigated the correlation between ... |
NA hydrochloride |
DL-NOREPINEPHRINE HCL |
DL-NORADRENALIN HYDROCHLORIDE |
UNII:7W3827X38V |
Arterenol hydrochloride |
EINECS 200-229-8 |
MFCD00012880 |
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol hydrochloride (1:1) |
DL-Norepinephrine hydrochloride |
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, hydrochloride (1:1) |
(±)-4-(2-amino-1-hydroxyethyl)-1,2-Benzenediol hydrochloride |
4-(2-Amino-1-hydroxyethyl)benzene-1,2-diol hydrochloride (1:1) |
DL-ARTERENOL HYDROCHLORIDE |
DL-ARTERENOL |